UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Re: “Timing of radiotherapy (RT) after radical prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047]”, by C. C. Parker et al. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4

Annals of oncology, 2024-08, Vol.35 (8), p.751-752

2024

Volltextzugriff (PDF)

Distribution of metastatic sites in renal cell carcinoma: a population-based analysis

Annals of oncology, 2012-04, Vol.23 (4), p.973-980

2012

Volltextzugriff (PDF)

SP-0022: Should oligometastatic disease in prostate cancer be treated systemically?: The urologist point of view

Radiotherapy and oncology, 2014, Vol.111, p.S6-S6

Briganti, A

2014

Volltextzugriff (PDF)

Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study

Annals of oncology, 2020-12, Vol.31 (12), p.1755-1763

2020

Volltextzugriff (PDF)

Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer

Oncogene, 2015-04, Vol.34 (16), p.2094-2102

2015

Volltextzugriff (PDF)

Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Annals of oncology, 2022-05, Vol.33 (5), p.561-561

2022

Volltextzugriff (PDF)

Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study

Annals of oncology, 2020-12, Vol.31 (12), p.1764-1772

2020

Volltextzugriff (PDF)

The impact of the time elapsed between primary treatment and BCR on cancer specific mortality in patients who experienced BCR after primary treatment

EUROPEAN UROLOGY, 2024, Vol.85, p.S1534-S1535

2024

Volltextzugriff (PDF)

Accuracy of the MRI 5-point Likert score to predict extra-prostatic extension and seminal vesicle invasion in patients undergoing radical prostatectomy for prostate cancer and development of a new MRI-based nomogram

EUROPEAN UROLOGY, 2024, Vol.85, p.S459-S460

2024

Volltextzugriff (PDF)

Cost effectiveness of prostate cancer testing incorporating Stockholm3 and MRI versus standard of care

EUROPEAN UROLOGY, 2024, Vol.85, p.S336-S337

2024

Volltextzugriff (PDF)

PSA response after radiotherapy. Is there a definition of PSA persistence after RT?

EUROPEAN UROLOGY, 2024, Vol.85, p.S1402-S1403

2024

Volltextzugriff (PDF)

Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial

European heart journal, 2006-11, Vol.27 (22), p.2632-2639

2006

Volltextzugriff (PDF)

Evaluation of bronchoalveolar lavage fluid from donkeys using four different cytological stains: A pilot study

Journal of equine veterinary science, 2024-04, Vol.135, p.105035-105035, Article 105035

2024

Volltextzugriff (PDF)

Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center

Annals of oncology, 2013-06, Vol.24 (6), p.1459-1466

2013

Volltextzugriff (PDF)

Identify the optimal candidates for adjuvant androgen deprivation therapy among patients with detectable PSA after radical prostatectomy

EUROPEAN UROLOGY, 2024, Vol.85, p.S1404-S1405

2024

Volltextzugriff (PDF)

Time to death and clinical characteristics of patients who died for prostate cancer after robot-assisted radical prostatectomy: 20 years’ report from the EAU Robotic Urology Section (ERUS) scientific working group

EUROPEAN UROLOGY, 2024, Vol.85, p.S1401

2024

Volltextzugriff (PDF)

Risk of upper urinary tract dissemination in cT3 bladder cancer patients treated with Double J stent versus nephrostomy tube prior to radical cystectomy

EUROPEAN UROLOGY, 2024, Vol.85, p.S1349-S1350

2024

Volltextzugriff (PDF)

Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study

Prostate cancer and prostatic diseases, 2017-06, Vol.20 (2), p.197-202

2017

Volltextzugriff (PDF)

The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology

World journal of urology, 2024-04, Vol.42 (1), p.248-248, Article 248

2024

Volltextzugriff (PDF)

Imaging biomarkers in prostate cancer: role of PET/CT and MRI

European journal of nuclear medicine and molecular imaging, 2015-04, Vol.42 (4), p.644-655

2015

Volltextzugriff (PDF)

Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates

International journal of clinical practice (Esher), 2013-06, Vol.67 (6), p.544-551

2013

Volltextzugriff (PDF)

Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience

European journal of surgical oncology, 2016-05, Vol.42 (5), p.735-743

2016

Volltextzugriff (PDF)

Understanding uranium behaviour in a natural rock–water system: leaching and adsorption tests on the Tufo Rosso a Scorie Nere ignimbrite (Viterbo area, central Italy)

Environmental earth sciences, 2017-10, Vol.76 (20), p.1-14, Article 680

2017

Volltextzugriff (PDF)

Mortality, Morbidity and Healthcare Expenditures After Local Tumour Ablation or Partial Nephrectomy For T1a Kidney Cancer

European journal of surgical oncology, 2017-04, Vol.43 (4), p.815-822

2017

Volltextzugriff (PDF)

Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial

Clinical genitourinary cancer, 2021-10, Vol.19 (5), p.457-465

2021

Volltextzugriff (PDF)

1 – 25 von 5.526

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.395)
Mit Volltextzugriff
(4.279)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect
(3.525)
Elsevier ScienceDirect Journals Complete
(2.978)
IngentaConnect Journals
(1.818)
Journals@Ovid Full Text
(1.698)
MEDLINE
(1.484)
Electronic Journals Library
(1.207)
Publisher or Other Site
(1.077)
Wiley Journals
(437)
Wiley Online Library Full Collection 2018
(307)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(295)
Springer Journals
(288)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(240)
Oxford Journals
(102)
SAGE Journals
(72)
Nature Journals
(68)
Taylor & Francis
(67)
Taylor & Francis Journals Auto-Holdings Collection
(64)
Taylor & Francis Online
(61)
Ebook Central Perpetual and DDA
(57)
eBooks on EBSCOhost
(56)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Re: “Timing of radiotherapy (RT) after radical prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047]”, by C. C. Parker et al. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4

Distribution of metastatic sites in renal cell carcinoma: a population-based analysis

SP-0022: Should oligometastatic disease in prostate cancer be treated systemically?: The urologist point of view

Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study

Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer

Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study

The impact of the time elapsed between primary treatment and BCR on cancer specific mortality in patients who experienced BCR after primary treatment

Accuracy of the MRI 5-point Likert score to predict extra-prostatic extension and seminal vesicle invasion in patients undergoing radical prostatectomy for prostate cancer and development of a new MRI-based nomogram

Cost effectiveness of prostate cancer testing incorporating Stockholm3 and MRI versus standard of care

PSA response after radiotherapy. Is there a definition of PSA persistence after RT?

Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial

Evaluation of bronchoalveolar lavage fluid from donkeys using four different cytological stains: A pilot study

Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center

Identify the optimal candidates for adjuvant androgen deprivation therapy among patients with detectable PSA after radical prostatectomy

Time to death and clinical characteristics of patients who died for prostate cancer after robot-assisted radical prostatectomy: 20 years’ report from the EAU Robotic Urology Section (ERUS) scientific working group

Risk of upper urinary tract dissemination in cT3 bladder cancer patients treated with Double J stent versus nephrostomy tube prior to radical cystectomy

Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study

The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology

Imaging biomarkers in prostate cancer: role of PET/CT and MRI

Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates

Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience

Understanding uranium behaviour in a natural rock–water system: leaching and adsorption tests on the Tufo Rosso a Scorie Nere ignimbrite (Viterbo area, central Italy)

Mortality, Morbidity and Healthcare Expenditures After Local Tumour Ablation or Partial Nephrectomy For T1a Kidney Cancer

Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial

Suchergebnisse filtern